img

Global Endoparasiticide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Endoparasiticide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Endoparasiticide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Endoparasiticide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Veterinary Hospitals or Clinics and Animal Farms are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Endoparasiticide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Endoparasiticide key manufacturers include Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc. Boehringer Ingelheim, Elanco, Zoetis are top 3 players and held % sales share in total in 2022.
Endoparasiticide can be divided into Ear Tags, Tablets, Injectables and Feed Additives, etc. Ear Tags is the mainstream product in the market, accounting for % sales share globally in 2022.
Endoparasiticide is widely used in various fields, such as Veterinary Hospitals or Clinics, Animal Farms and Home Care Settings,, etc. Veterinary Hospitals or Clinics provides greatest supports to the Endoparasiticide industry development. In 2022, global % sales of Endoparasiticide went into Veterinary Hospitals or Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endoparasiticide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Segment by Type
Ear Tags
Tablets
Injectables
Feed Additives

Segment by Application


Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endoparasiticide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Endoparasiticide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Endoparasiticide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Endoparasiticide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Endoparasiticide introduction, etc. Endoparasiticide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Endoparasiticide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Endoparasiticide Market Overview
1.1 Endoparasiticide Product Overview
1.2 Endoparasiticide Market Segment by Type
1.2.1 Ear Tags
1.2.2 Tablets
1.2.3 Injectables
1.2.4 Feed Additives
1.3 Global Endoparasiticide Market Size by Type
1.3.1 Global Endoparasiticide Market Size Overview by Type (2018-2034)
1.3.2 Global Endoparasiticide Historic Market Size Review by Type (2018-2024)
1.3.3 Global Endoparasiticide Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Endoparasiticide Sales Breakdown by Type (2018-2024)
1.4.2 Europe Endoparasiticide Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Endoparasiticide Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Endoparasiticide Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Endoparasiticide Sales Breakdown by Type (2018-2024)
2 Global Endoparasiticide Market Competition by Company
2.1 Global Top Players by Endoparasiticide Sales (2018-2024)
2.2 Global Top Players by Endoparasiticide Revenue (2018-2024)
2.3 Global Top Players by Endoparasiticide Price (2018-2024)
2.4 Global Top Manufacturers Endoparasiticide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Endoparasiticide Market Competitive Situation and Trends
2.5.1 Endoparasiticide Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Endoparasiticide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoparasiticide as of 2022)
2.7 Date of Key Manufacturers Enter into Endoparasiticide Market
2.8 Key Manufacturers Endoparasiticide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Endoparasiticide Status and Outlook by Region
3.1 Global Endoparasiticide Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Endoparasiticide Historic Market Size by Region
3.2.1 Global Endoparasiticide Sales in Volume by Region (2018-2024)
3.2.2 Global Endoparasiticide Sales in Value by Region (2018-2024)
3.2.3 Global Endoparasiticide Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Endoparasiticide Forecasted Market Size by Region
3.3.1 Global Endoparasiticide Sales in Volume by Region (2024-2034)
3.3.2 Global Endoparasiticide Sales in Value by Region (2024-2034)
3.3.3 Global Endoparasiticide Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Endoparasiticide by Application
4.1 Endoparasiticide Market Segment by Application
4.1.1 Veterinary Hospitals or Clinics
4.1.2 Animal Farms
4.1.3 Home Care Settings
4.2 Global Endoparasiticide Market Size by Application
4.2.1 Global Endoparasiticide Market Size Overview by Application (2018-2034)
4.2.2 Global Endoparasiticide Historic Market Size Review by Application (2018-2024)
4.2.3 Global Endoparasiticide Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Endoparasiticide Sales Breakdown by Application (2018-2024)
4.3.2 Europe Endoparasiticide Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Endoparasiticide Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Endoparasiticide Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Endoparasiticide Sales Breakdown by Application (2018-2024)
5 North America Endoparasiticide by Country
5.1 North America Endoparasiticide Historic Market Size by Country
5.1.1 North America Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Endoparasiticide Sales in Volume by Country (2018-2024)
5.1.3 North America Endoparasiticide Sales in Value by Country (2018-2024)
5.2 North America Endoparasiticide Forecasted Market Size by Country
5.2.1 North America Endoparasiticide Sales in Volume by Country (2024-2034)
5.2.2 North America Endoparasiticide Sales in Value by Country (2024-2034)
6 Europe Endoparasiticide by Country
6.1 Europe Endoparasiticide Historic Market Size by Country
6.1.1 Europe Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Endoparasiticide Sales in Volume by Country (2018-2024)
6.1.3 Europe Endoparasiticide Sales in Value by Country (2018-2024)
6.2 Europe Endoparasiticide Forecasted Market Size by Country
6.2.1 Europe Endoparasiticide Sales in Volume by Country (2024-2034)
6.2.2 Europe Endoparasiticide Sales in Value by Country (2024-2034)
7 Asia-Pacific Endoparasiticide by Region
7.1 Asia-Pacific Endoparasiticide Historic Market Size by Region
7.1.1 Asia-Pacific Endoparasiticide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Endoparasiticide Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Endoparasiticide Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Endoparasiticide Forecasted Market Size by Region
7.2.1 Asia-Pacific Endoparasiticide Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Endoparasiticide Sales in Value by Region (2024-2034)
8 Latin America Endoparasiticide by Country
8.1 Latin America Endoparasiticide Historic Market Size by Country
8.1.1 Latin America Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Endoparasiticide Sales in Volume by Country (2018-2024)
8.1.3 Latin America Endoparasiticide Sales in Value by Country (2018-2024)
8.2 Latin America Endoparasiticide Forecasted Market Size by Country
8.2.1 Latin America Endoparasiticide Sales in Volume by Country (2024-2034)
8.2.2 Latin America Endoparasiticide Sales in Value by Country (2024-2034)
9 Middle East and Africa Endoparasiticide by Country
9.1 Middle East and Africa Endoparasiticide Historic Market Size by Country
9.1.1 Middle East and Africa Endoparasiticide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Endoparasiticide Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Endoparasiticide Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Endoparasiticide Forecasted Market Size by Country
9.2.1 Middle East and Africa Endoparasiticide Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Endoparasiticide Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Boehringer Ingelheim Endoparasiticide Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 Elanco
10.2.1 Elanco Company Information
10.2.2 Elanco Introduction and Business Overview
10.2.3 Elanco Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Elanco Endoparasiticide Products Offered
10.2.5 Elanco Recent Development
10.3 Zoetis
10.3.1 Zoetis Company Information
10.3.2 Zoetis Introduction and Business Overview
10.3.3 Zoetis Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Zoetis Endoparasiticide Products Offered
10.3.5 Zoetis Recent Development
10.4 Merck
10.4.1 Merck Company Information
10.4.2 Merck Introduction and Business Overview
10.4.3 Merck Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Merck Endoparasiticide Products Offered
10.4.5 Merck Recent Development
10.5 Virbac
10.5.1 Virbac Company Information
10.5.2 Virbac Introduction and Business Overview
10.5.3 Virbac Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Virbac Endoparasiticide Products Offered
10.5.5 Virbac Recent Development
10.6 Novartis AG
10.6.1 Novartis AG Company Information
10.6.2 Novartis AG Introduction and Business Overview
10.6.3 Novartis AG Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis AG Endoparasiticide Products Offered
10.6.5 Novartis AG Recent Development
10.7 Ceva Sante Animlae
10.7.1 Ceva Sante Animlae Company Information
10.7.2 Ceva Sante Animlae Introduction and Business Overview
10.7.3 Ceva Sante Animlae Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ceva Sante Animlae Endoparasiticide Products Offered
10.7.5 Ceva Sante Animlae Recent Development
10.8 Bayer AG
10.8.1 Bayer AG Company Information
10.8.2 Bayer AG Introduction and Business Overview
10.8.3 Bayer AG Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bayer AG Endoparasiticide Products Offered
10.8.5 Bayer AG Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly Endoparasiticide Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Vetoquinol
10.10.1 Vetoquinol Company Information
10.10.2 Vetoquinol Introduction and Business Overview
10.10.3 Vetoquinol Endoparasiticide Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Vetoquinol Endoparasiticide Products Offered
10.10.5 Vetoquinol Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Endoparasiticide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Endoparasiticide Industrial Chain Analysis
11.4 Endoparasiticide Market Dynamics
11.4.1 Endoparasiticide Industry Trends
11.4.2 Endoparasiticide Market Drivers
11.4.3 Endoparasiticide Market Challenges
11.4.4 Endoparasiticide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Endoparasiticide Distributors
12.3 Endoparasiticide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Ear Tags
Table 2. Major Company of Tablets
Table 3. Major Company of Injectables
Table 4. Major Company of Feed Additives
Table 5. Global Endoparasiticide Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Endoparasiticide Sales by Type (2018-2024) & (K Units)
Table 7. Global Endoparasiticide Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Endoparasiticide Sales by Type (2018-2024) & (US& Million)
Table 9. Global Endoparasiticide Market Share in Value by Type (2018-2024)
Table 10. Global Endoparasiticide Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Endoparasiticide Sales by Type (2024-2034) & (K Units)
Table 12. Global Endoparasiticide Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Endoparasiticide Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Endoparasiticide Sales Market Share in Value by Type (2024-2034)
Table 15. Global Endoparasiticide Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Endoparasiticide Sales by Type (2018-2024) & (K Units)
Table 17. North America Endoparasiticide Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Endoparasiticide Sales (K Units) by Type (2018-2024)
Table 19. Europe Endoparasiticide Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Endoparasiticide Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Endoparasiticide Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Endoparasiticide Sales (K Units) by Type (2018-2024)
Table 23. Latin America Endoparasiticide Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Endoparasiticide Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Endoparasiticide Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Endoparasiticide Sales by Company (2018-2024) & (K Units)
Table 27. Global Endoparasiticide Sales Share by Company (2018-2024)
Table 28. Global Endoparasiticide Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Endoparasiticide Revenue Share by Company (2018-2024)
Table 30. Global Market Endoparasiticide Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Endoparasiticide Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Endoparasiticide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Endoparasiticide as of 2022)
Table 34. Date of Key Manufacturers Enter into Endoparasiticide Market
Table 35. Key Manufacturers Endoparasiticide Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Endoparasiticide Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Endoparasiticide Sales by Region (2018-2024) & (K Units)
Table 39. Global Endoparasiticide Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Endoparasiticide Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Endoparasiticide Sales Market Share in Value by Region (2018-2024)
Table 42. Global Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Endoparasiticide Sales by Region (2024-2034) & (K Units)
Table 44. Global Endoparasiticide Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Endoparasiticide Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Endoparasiticide Sales Market Share in Value by Region (2024-2034)
Table 47. Global Endoparasiticide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Endoparasiticide Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Endoparasiticide Sales by Application (2018-2024) & (K Units)
Table 50. Global Endoparasiticide Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Endoparasiticide Sales Market Share in Value by Application (2018-2024)
Table 53. Global Endoparasiticide Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Endoparasiticide Sales by Application (2024-2034) & (K Units)
Table 55. Global Endoparasiticide Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Endoparasiticide Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Endoparasiticide Sales Market Share in Value by Application (2024-2034)
Table 58. Global Endoparasiticide Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Endoparasiticide Sales by Application (2018-2024) (K Units)
Table 60. North America Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Endoparasiticide Sales by Application (2018-2024) (K Units)
Table 62. Europe Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Endoparasiticide Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Endoparasiticide Sales by Application (2018-2024) (K Units)
Table 66. Latin America Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Endoparasiticide Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Endoparasiticide Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Endoparasiticide Sales by Country (2018-2024) & (K Units)
Table 70. North America Endoparasiticide Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Endoparasiticide Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Endoparasiticide Sales Market Share in Value by Country (2018-2024)
Table 73. North America Endoparasiticide Sales by Country (2024-2034) & (K Units)
Table 74. North America Endoparasiticide Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Endoparasiticide Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Endoparasiticide Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Endoparasiticide Sales by Country (2018-2024) & (K Units)
Table 78. Europe Endoparasiticide Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Endoparasiticide Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Endoparasiticide Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Endoparasiticide Sales by Country (2024-2034) & (K Units)
Table 82. Europe Endoparasiticide Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Endoparasiticide Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Endoparasiticide Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Endoparasiticide Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Endoparasiticide Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Endoparasiticide Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Endoparasiticide Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Endoparasiticide Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Endoparasiticide Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Endoparasiticide Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Endoparasiticide Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Endoparasiticide Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Endoparasiticide Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Endoparasiticide Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Endoparasiticide Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Endoparasiticide Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Endoparasiticide Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Endoparasiticide Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Endoparasiticide Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Endoparasiticide Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Endoparasiticide Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Endoparasiticide Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Endoparasiticide Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Endoparasiticide Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Endoparasiticide Sales Market Share in Value by Country (2024-2034)
Table 109. Boehringer Ingelheim Company Information
Table 110. Boehringer Ingelheim Introduction and Business Overview
Table 111. Boehringer Ingelheim Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Boehringer Ingelheim Endoparasiticide Product
Table 113. Boehringer Ingelheim Recent Development
Table 114. Elanco Company Information
Table 115. Elanco Introduction and Business Overview
Table 116. Elanco Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Elanco Endoparasiticide Product
Table 118. Elanco Recent Development
Table 119. Zoetis Company Information
Table 120. Zoetis Introduction and Business Overview
Table 121. Zoetis Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Zoetis Endoparasiticide Product
Table 123. Zoetis Recent Development
Table 124. Merck Company Information
Table 125. Merck Introduction and Business Overview
Table 126. Merck Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Merck Endoparasiticide Product
Table 128. Merck Recent Development
Table 129. Virbac Company Information
Table 130. Virbac Introduction and Business Overview
Table 131. Virbac Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Virbac Endoparasiticide Product
Table 133. Virbac Recent Development
Table 134. Novartis AG Company Information
Table 135. Novartis AG Introduction and Business Overview
Table 136. Novartis AG Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Novartis AG Endoparasiticide Product
Table 138. Novartis AG Recent Development
Table 139. Ceva Sante Animlae Company Information
Table 140. Ceva Sante Animlae Introduction and Business Overview
Table 141. Ceva Sante Animlae Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Ceva Sante Animlae Endoparasiticide Product
Table 143. Ceva Sante Animlae Recent Development
Table 144. Bayer AG Company Information
Table 145. Bayer AG Introduction and Business Overview
Table 146. Bayer AG Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Bayer AG Endoparasiticide Product
Table 148. Bayer AG Recent Development
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Introduction and Business Overview
Table 151. Eli Lilly Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Eli Lilly Endoparasiticide Product
Table 153. Eli Lilly Recent Development
Table 154. Vetoquinol Company Information
Table 155. Vetoquinol Introduction and Business Overview
Table 156. Vetoquinol Endoparasiticide Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Vetoquinol Endoparasiticide Product
Table 158. Vetoquinol Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Endoparasiticide Market Trends
Table 162. Endoparasiticide Market Drivers
Table 163. Endoparasiticide Market Challenges
Table 164. Endoparasiticide Market Restraints
Table 165. Endoparasiticide Distributors List
Table 166. Endoparasiticide Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Endoparasiticide Product Picture
Figure 2. Global Endoparasiticide Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Endoparasiticide Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Endoparasiticide Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Ear Tags
Figure 6. Global Ear Tags Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Tablets
Figure 8. Global Tablets Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Injectables
Figure 10. Global Injectables Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Feed Additives
Figure 12. Global Feed Additives Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Endoparasiticide Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Endoparasiticide Sales Market Share by Type in 2022 & 2034
Figure 15. North America Endoparasiticide Sales Market Share in Volume by Type in 2022
Figure 16. North America Endoparasiticide Sales Market Share in Value by Type in 2022
Figure 17. Europe Endoparasiticide Sales Market Share in Volume by Type in 2022
Figure 18. Europe Endoparasiticide Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Endoparasiticide Sales Market Share in Value by Type in 2022
Figure 21. Latin America Endoparasiticide Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Endoparasiticide Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Endoparasiticide Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Endoparasiticide Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Endoparasiticide Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Endoparasiticide Revenue in 2022
Figure 27. Endoparasiticide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Veterinary Hospitals or Clinics
Figure 29. Global Veterinary Hospitals or Clinics Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Animal Farms
Figure 31. Global Animal Farms Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Home Care Settings
Figure 33. Global Home Care Settings Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Global Endoparasiticide Sales by Application (2018-2034) & (US$ Million)
Figure 35. Global Endoparasiticide Sales Market Share by Application in 2022 & 2034
Figure 36. North America Endoparasiticide Sales Market Share in Volume by Application in 2022
Figure 37. North America Endoparasiticide Sales Market Share in Value by Application in 2022
Figure 38. Europe Endoparasiticide Sales Market Share in Volume by Application in 2022
Figure 39. Europe Endoparasiticide Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Endoparasiticide Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Endoparasiticide Sales Market Share in Value by Application in 2022
Figure 42. Latin America Endoparasiticide Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Endoparasiticide Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Endoparasiticide Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Endoparasiticide Manufacturing Cost Structure
Figure 47. Endoparasiticide Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed